Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer

NCT06065813 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer
Neoadjuvant Therapy
Radiotherapy
Immunotherapy

Interventions

DRUG: Toripalimab
RADIATION: Conventional segmental radiotherapy
OTHER: opreation

Sponsor

Northern Jiangsu People's Hospital

Collaborators

[object Object]